Performance and clinical decision-making using the prognostic 40-gene expression profile (40-GEP) test in 1,018 patients with high-risk cutaneous squamous cell carcinoma (SCC)

Main Article Content

Jennifer J Siegel
Castle Biosciences

Anesh Prasai
Castle Biosciences

Aaron S Farberg
Baylor Scott & White Health System

Matthew S Goldberg
Icahn School of Medicine at Mount Sinai Department of Dermatology

Keywords

high-risk, cutaneous squamous cell carcinoma, 40-gene expression profile, 40-GEP, performance, clinical decision-making, prognosis

References

1. Rogers, JAMA Derm 2015

2. Karia, JAAD 2013

3. Cañueto, JAAD 2019

4. Ruiz, JAMA Derm 2019

5. NCCN Guidelines V2.2022

6. Wysong, JAAD 2021

7. Ibrahim, Future Onc 2021

8. Hooper, Cancer Inv 2022

9. Teplitz, JDD 2019

Article Sidebar

Poster PDF
Published
Nov 16, 2022
DOI https://doi.org/10.25251/skin.6.supp.96

Article Details

How to Cite
Siegel, J. J., Prasai, A., Farberg, A. S., & Goldberg, M. S. (2022). Performance and clinical decision-making using the prognostic 40-gene expression profile (40-GEP) test in 1,018 patients with high-risk cutaneous squamous cell carcinoma (SCC). SKIN The Journal of Cutaneous Medicine, 6(6), s96. https://doi.org/10.25251/skin.6.supp.96
Issue
Vol. 6 No. 6 (2022): November Issue & Poster Presentations from FC22 Dermatology Conference®
Section
Skin Cancer
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

1 2 > >>